Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Alternative treatments show promise for hair growth beyond traditional methods.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

A group has developed therapies that show promise for treating cancer and various other conditions.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Prolactin may be important for skin growth and immune function.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.